Bionamic offers a comprehensive software platform designed specifically for antibody discovery and development, accessible through a browser-based application. This platform serves as a single source of truth for all data related to antibody research, enabling users to analyze assays, annotate sequences, and track inventory efficiently. It supports the entire workflow from research to development, allowing for the automation of processes through user-defined scripts. The application facilitates powerful visualization and bioinformatics capabilities, enabling researchers to select candidates, align sequences, and manage data from various sources, including contract research organizations (CROs). 

The platform emphasizes collaboration and traceability, ensuring that every change made to the data is recorded with details on who made the change and when. Bionamic's cloud-based system functions similarly to version control systems, allowing users to commit changes, revert to previous versions, and maintain a clear history of data modifications. It also supports custom imports and automated cloning, making it easier for researchers to manage complex tasks such as aligning sequences, calculating biophysical properties, and generating antibodies from specific sequences. Overall, Bionamic's technology streamlines the antibody research process, enhancing efficiency and accuracy in candidate selection and development.

Sweden

Bionamic was founded by researchers to address the frustrating challenge of implementing digitalization in biopharma R&D. Our software platform can serve as a single source of truth for all your antibody related discovery and development data and offers an easy way to navigate it. We have put an incredible amount of thought and effort into making sure the data can be represented in a way that makes sense and helps to solve real problems.

Bionamic

Company Details